Found 4 hits for monomerid = 204120 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204120
(US9539260, K | US9763952, Example K)Show SMILES COc1ncc(cc1C#N)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)[C@@H]3CCN(C3)C(C)=O)cc12 |r| Show InChI InChI=1S/C26H29N5O5/c1-17(32)29-7-5-18(15-29)26(33)30-8-6-22(16-30)36-21-3-4-24-23(12-21)31(9-10-35-24)20-11-19(13-27)25(34-2)28-14-20/h3-4,11-12,14,18,22H,5-10,15-16H2,1-2H3/t18-,22+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 393 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204120
(US9539260, K | US9763952, Example K)Show SMILES COc1ncc(cc1C#N)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)[C@@H]3CCN(C3)C(C)=O)cc12 |r| Show InChI InChI=1S/C26H29N5O5/c1-17(32)29-7-5-18(15-29)26(33)30-8-6-22(16-30)36-21-3-4-24-23(12-21)31(9-10-35-24)20-11-19(13-27)25(34-2)28-14-20/h3-4,11-12,14,18,22H,5-10,15-16H2,1-2H3/t18-,22+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | <3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204120
(US9539260, K | US9763952, Example K)Show SMILES COc1ncc(cc1C#N)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)[C@@H]3CCN(C3)C(C)=O)cc12 |r| Show InChI InChI=1S/C26H29N5O5/c1-17(32)29-7-5-18(15-29)26(33)30-8-6-22(16-30)36-21-3-4-24-23(12-21)31(9-10-35-24)20-11-19(13-27)25(34-2)28-14-20/h3-4,11-12,14,18,22H,5-10,15-16H2,1-2H3/t18-,22+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 393 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| Assay Description The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and p... |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204120
(US9539260, K | US9763952, Example K)Show SMILES COc1ncc(cc1C#N)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)[C@@H]3CCN(C3)C(C)=O)cc12 |r| Show InChI InChI=1S/C26H29N5O5/c1-17(32)29-7-5-18(15-29)26(33)30-8-6-22(16-30)36-21-3-4-24-23(12-21)31(9-10-35-24)20-11-19(13-27)25(34-2)28-14-20/h3-4,11-12,14,18,22H,5-10,15-16H2,1-2H3/t18-,22+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | <3 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |